Straightforward accreditation standards: Teams will save time and effort by creating workflows around accreditation standards ...

Astellas Pharma has unveiled encouraging preliminary findings from its ongoing phase 4 OPTION-VMS observational study, ...

ENA Respiratory has raised US$22.4m (AU$34m) in Series B financing to support the phase 2 clinical development of its nasal ...

Nxera Pharma and its partner Cancer Research UK have presented encouraging results from the completed phase 1 portion of ...

The Global Fund has welcomed a £6 million joint investment from GSK and ViiV Healthcare to strengthen community-led responses ...

Janssen-Cilag International NV, part of Johnson & Johnson, has announced encouraging results from the phase 1b/2 OrigAMI-4 ...

New data from the PROCLIPI study has shown a meaningful overall survival benefit for patients with advanced cutaneous T-cell ...

AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for ...

The National Institute for Health and Care Research (NIHR) has announced a £157 million investment over 5 years to support 10 ...

Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro ...

Under the terms of the deal, Biossil will receive worldwide rights to develop remetinostat, which has shown positive data in basal cell carcinoma and cutaneous T-cell lymphoma. If successfully ...

Artificial intelligence tools that could revolutionise patient care are being trialled in phase 2 of the Medicines and ...